DK1603919T3 - 7-Iminoderivater af camptothecin med antitumoraktivitet - Google Patents

7-Iminoderivater af camptothecin med antitumoraktivitet

Info

Publication number
DK1603919T3
DK1603919T3 DK04719039T DK04719039T DK1603919T3 DK 1603919 T3 DK1603919 T3 DK 1603919T3 DK 04719039 T DK04719039 T DK 04719039T DK 04719039 T DK04719039 T DK 04719039T DK 1603919 T3 DK1603919 T3 DK 1603919T3
Authority
DK
Denmark
Prior art keywords
camptothecin
antitumor activity
imino derivatives
imino
derivatives
Prior art date
Application number
DK04719039T
Other languages
Danish (da)
English (en)
Inventor
Sabrina Dallavalle
Sergio Penco
C Pisano
F Zunino
Original Assignee
Sigma Tau Ind Farmaceuti
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti, Ist Naz Stud Cura Dei Tumori filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1603919T3 publication Critical patent/DK1603919T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK04719039T 2003-03-17 2004-03-10 7-Iminoderivater af camptothecin med antitumoraktivitet DK1603919T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/388,587 US7105492B2 (en) 1999-03-09 2003-03-17 Camptothecin derivatives having antitumor activity
PCT/IT2004/000118 WO2004083214A1 (en) 2003-03-17 2004-03-10 7-imino derivatives of camptothecin having antitumor activity

Publications (1)

Publication Number Publication Date
DK1603919T3 true DK1603919T3 (da) 2009-03-09

Family

ID=33029646

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04719039T DK1603919T3 (da) 2003-03-17 2004-03-10 7-Iminoderivater af camptothecin med antitumoraktivitet

Country Status (20)

Country Link
US (2) US7105492B2 (zh)
EP (1) EP1603919B1 (zh)
JP (1) JP4791355B2 (zh)
KR (1) KR101174112B1 (zh)
CN (1) CN100372855C (zh)
AR (1) AR043620A1 (zh)
AT (1) ATE417851T1 (zh)
AU (1) AU2004222044B2 (zh)
BR (1) BRPI0408380A (zh)
CA (1) CA2517450C (zh)
CY (1) CY1108890T1 (zh)
DE (1) DE602004018468D1 (zh)
DK (1) DK1603919T3 (zh)
ES (1) ES2319293T3 (zh)
HK (1) HK1089160A1 (zh)
PL (1) PL1603919T3 (zh)
PT (1) PT1603919E (zh)
SI (1) SI1603919T1 (zh)
TW (1) TWI341840B (zh)
WO (1) WO2004083214A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7105492B2 (en) * 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity
ITRM20030344A1 (it) * 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
ITRM20040288A1 (it) * 2004-06-11 2004-09-11 Sigma Tau Ind Farmaceuti Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.
EP1827437B1 (en) * 2004-12-15 2011-11-02 Novartis AG Combinations of therapeutic agents for treating cancer
US7291936B1 (en) * 2006-05-03 2007-11-06 Robson John H Submersible electrical power generating plant
CN102731516B (zh) * 2011-04-07 2014-07-02 宁波天衡药业股份有限公司 一类具有抗肿瘤活性的喜树碱衍生物
EP4267140A1 (en) * 2020-12-23 2023-11-01 Shanghai Ruotuo Biosciences Co., Ltd. Antibody-drug conjugates, pharmaceutical compositions, and therapeutic applications

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
JPS58154582A (ja) * 1982-03-10 1983-09-14 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造法
EP0612248B1 (en) * 1991-11-15 2003-08-20 Smithkline Beecham Corporation Composition containing cisplatin and topotecan as antitumor agent.
US5614529A (en) * 1994-09-22 1997-03-25 Research Triangle Institute Inhibition of plasmodia parasites by camptothecin compounds
US5972955A (en) * 1995-06-06 1999-10-26 Dr. Reddy's Research Foundation Water soluble C-ring analogues of 20(S)-camptothecin
IT1282673B1 (it) 1996-02-23 1998-03-31 Ist Naz Stud Cura Dei Tumori Derivati della camptotecina e loro uso come agenti antitumorali
CN1107678C (zh) 1996-08-19 2003-05-07 比奥纽默里克药物公司 高亲脂性喜树碱衍生物,其制备方法及其用途
EP1044977B1 (en) * 1999-03-09 2002-05-02 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Camptothecin derivatives having antitumor activity
US7105492B2 (en) * 1999-03-09 2006-09-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Camptothecin derivatives having antitumor activity

Also Published As

Publication number Publication date
CA2517450C (en) 2011-06-14
TW200504076A (en) 2005-02-01
ATE417851T1 (de) 2009-01-15
BRPI0408380A (pt) 2006-03-21
CN1761668A (zh) 2006-04-19
US7105492B2 (en) 2006-09-12
US7351714B2 (en) 2008-04-01
HK1089160A1 (en) 2006-11-24
ES2319293T3 (es) 2009-05-06
EP1603919A1 (en) 2005-12-14
KR20050107756A (ko) 2005-11-15
AU2004222044B2 (en) 2010-02-25
CA2517450A1 (en) 2004-09-30
TWI341840B (en) 2011-05-11
JP4791355B2 (ja) 2011-10-12
US20040018988A1 (en) 2004-01-29
DE602004018468D1 (de) 2009-01-29
PT1603919E (pt) 2009-02-16
US20060167033A1 (en) 2006-07-27
AU2004222044A1 (en) 2004-09-30
KR101174112B1 (ko) 2012-08-16
SI1603919T1 (sl) 2009-04-30
PL1603919T3 (pl) 2009-06-30
WO2004083214A1 (en) 2004-09-30
JP2006520807A (ja) 2006-09-14
CN100372855C (zh) 2008-03-05
EP1603919B1 (en) 2008-12-17
AR043620A1 (es) 2005-08-03
CY1108890T1 (el) 2014-07-02

Similar Documents

Publication Publication Date Title
DK1802579T3 (da) Derivater af 3-arylaminopyridin
ATE450528T1 (de) Chinazolinderivate als antitumormittel
DK1580216T3 (da) Derivater med høj molekylvægt af camptotheciner
ATE512960T1 (de) Pyrimidinderivate
MA28396B1 (fr) Dérivés de quinoléine nouveaux
MA28824B1 (fr) Derives de pyrimidine
DK1791820T3 (da) Enantioselektiv fremstilling af quinolinderivater
ATE340782T1 (de) Piperidinbenzolsulfonamidderivate
DK1044977T3 (da) Camptothecinderivater med antitumoraktivitet
DK1622880T3 (da) Substituerede dihydroquinazoliner med antivirale egenskaber
NO20054136D0 (no) Imidazol-4-yl-etynyl-pyridin-derivater
ATE394399T1 (de) Tetrahydropyridoindolderivate
DK1753764T3 (da) Pyrrolopyridin-derivater
ATE383361T1 (de) Pyrrazolopyrimidinderivate
ATE413389T1 (de) Chinazolinderivate
DE602004022180D1 (de) Chinazolinderivate
DE602004004553D1 (de) Chinazolinderivate
ATE420066T1 (de) Amidoacetonitrilderivate
ATE417830T1 (de) Sulfonylbenzimidazolderivate
NO20054854D0 (no) Femrings heterocykliske derivater
IS8045A (is) Púrín-6-ón-afleiður
ATE404542T1 (de) 4-phenylpyrimidin-2-carbonitrilderivate
ATE354365T1 (de) N-thiazol-2-yl-benzamid-derivate
HK1089160A1 (en) 7-imino derivatives of camptothecin having antitumor activity
ATE365731T1 (de) 4-amino-5-cyanopyrimidinderivate